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An interaction between thymus or thoracic duct cells and  antibody-forming 
cell precursors has been implicated in the response of mice to sheep erythro- 
cytes (1). The possibility was raised that the thymus contributes cells to the 
circulating  pool  of lymphocytes which  recognize  antigen  (ARC)  and  which 
influence  the  differentiation  of  antibody-forming cell  precursors  (AFCP)  to 
hemolysin-forming  cells.  The  experimental  system  employing  reconstituted 
neonatally  thymectomized mice  failed  to  detect  the  existence  of  AFCP  in 
inoculated lymphoid cell suspensions. 
Previous  work  from  this  laboratory  (2)  had  demonstrated  that  thoracic 
duct  and  spleen  cells were capable of affecting the  appearance of hemolytic 
foci in the spleens of heavily irradiated recipients injected with sheep erythro- 
cytes. If such loci represent clusters of antibody-forming cells, then either the 
inoculum must contain  cells potentially capable of producing hemolysins, or 
the host must provide AFCP which are extremely radio-resistant. 
In this  paper, we present the results of experiments designed to determine 
whether both ARC and AFCP are present in populations of cells from thymus, 
thoracic duct lymph, or bone marrow. 
Materials and Methods 
A,imals.--Mice of the highly inbred strains CBA and C57BL, and Ft hybrids from crosses 
between these strains were used. The origin and maintenance of these mice have been de- 
scribed in the previous paper (1). 
Cell suspensions were prepared as before (1). 
0t~¢ra~i~e Procedures.--Thymeetomy or sham  operation was performed in young adult 
mice, 4--6 wk old, as previously described (3). Checks for the presence of thymus remnants 
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were made at autopsy and mice with such remnants  were discarded from the experiments. 
Thoracic duct cannulation was performed as described in the previous paper  (1). 
lrradiagon.--Intact or adult thymectomized mice were exposed to total-body irradiation 
in a  Perspex box. In the case of thymectomized mice, the irradiation was performed i-3 wk 
after thymectomy. The dose given was 800  fads to mid-point with maximum back  scatter 
conditions and the machine operated under conditions given in the previous paper  (1). The 
focal skin distance was 50 cm and  the absorbed  dose rate was  170 rads per minute.  When 
thymectomized irradiated  mice were to be protected with bone marrow,  they received an 
intravenous injection of 2-5 million cells in 0.1-O.2 ml Dulbecco's phosphate-buffered saline 
1-3 hr postirradlation. All irradiated mice were given oxytetracycline  1 (100 mg per liter) or 
penicillin  2 (600,000 units per liter) in the drinking water. 
Assays for  Hemolysin Plaffue--Forming Cells and Hemolytic Foci.--Hemoly'An plaque- 
forming ceils were assayed according to the technique of Jeme et al. (4). The hemolytic focus 
assay  used  in the present experiments was a  modification of the  techniques described  by 
Kennedy et al. (5) and Playfair et al. (6). The spleens were not frozen but serially sectioned 
into 250-/z segments by means of a  tissue chopper  8 and sequentially transferred  with forceps 
to an agar plate. These plates were then heated to 37°C and double the quantity of the top, 
soft agar layer as used in the Jerue assay, was poured over the segments. This layer contained 
3.8 ml of 1.4% agar in double strength Eagle's medium, 2 mg dextran, and 0.2  ml of 20% 
sheep erythrocytes. After incubation for 1-2 hr,  1:10 guinea pig serum was added and  the 
plates incubated for a further hour. The serum was then removed and  the plates cooled to 
4°C. The red cells were stained with benzidine  4 for 1-2 rain to increase the contrast between 
the areas of hemolysis which had developed around  the segments  and  the intact red cells. 
Immediately after staining,  the hemolytic areas were counted  with the aid of a  dissecting 
microscope. 
Preparation of Anti-H2 Sera and Invubation of Plaque-Forming Cells.--The methods for 
preparing  specific  anti-H2  sera and  for  incubating plaque-forming cells were given in  the 
preceding paper (1). 
Statistical Analysis.--The standard errors of the means were calculated and P  values deter- 
mined by Student's t test. 
RESULTS 
Effect of Syngeneic Thymus,  Thoracic Duct, or Bone Marrow Cells in Irradi- 
ated Hosts.--lO million CBA thoracic duct cells, thymus  cells, or bone marrow 
cells were  injected  together  with  l0  s  SRBC 5 into  groups  of syngeneic  recipi- 
ents that had  been exposed  to 800 rads  total-body irradiation.  The number  of 
PFC  per  spleen  was  determined  7  days  later.  As  seen  in Table  I,  10  million 
thoracic duct cells produced  on the average 1270 PFC  whereas  I0 million thy- 
t Terramycin, Pfizer Pty Ltd.,  Sydney, Australia. 
2 Crystalline Penicillin G, Evans Medical Australia  (Pty) Ltd.,  Sydney, Australia. 
8 McIlwain's tissue chopper  (7),  Mickle Laboratory  Engineering Co., Mill Works,  Gore- 
shall,  Surrey, England. 
4 1 part  of 5% hydrogen peroxide to 9  parts  of 0.555%  benzidine in  12.5%  acetic acid 
kept  at 4°C. 
5The  following abbreviations  are  used:  SRBC,  sheep  erythrocytes;  PFC,  hemolysin 
plaque-forming cells; AFCP, antibody-forming cell precursors; ARC, antigen-reactive cells; 
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mus ceils did not increase the number of PFC above that obtained in irradiated 
mice given SRBC alone. Increasing the number of thymus cells to 50 million 
increased the average number of PFC to only 45. Injection of 25 million tho- 
racic duct cells in the absence of antigen did not cause any elevation above the 
background number of 15 PFC per spleen. Similarly, bone marrow ceils were 
ineffective. 
During investigations of the hemolytic focus-producing capacity of thoracic 
duct and spleen cell inocula (2) it was noted that the foci produced by thoracic 
duct cells involved only one or two consecutive segments of the sliced spleens. 
With spleen cell inocula, hemopoietic regeneration occurred in the irradiated 
spleens and individual hemolytic loci often extended over three or four seg- 
TABLE  I 
PFC Produced in the Spleens of Heavily Irradiated CBA  Mice after Injecl~on of SRBC and 
S)mgend~ Thymus, Bone Marrow, or Thoracic Duct Cells 
Average  PFC  per  spleen 
Cells inoculated  No. of mice  i 8 days postirradistion 
(± st) 
SRBC only 
10 X  lot thymus cells "4- SRBC 
50 X 10  t thymus ceils q- SRBC 
10 X lot bone marrow cells 4" SRBC 
25 X  Iot  thoracic  duct cells  only 
10 X  lot  thoracic  duct cells  +  SRBC 
16 
14 
8 
16 
5 
23 
15  4-6.1 
15  4-  3.0 
45  -4-- 5.0 
27  4-  5.8 
17  4-  4.4 
1270  4-  338* 
* P  <  0.05-<  0.01 when this value is compared with those in all other groups. 
ments. To investigate whatever effect hemopoietic regeneration might have on 
the size of hemolytic foci produced by thoracic duct cells, bone marrow cells 
were  injected simultaneously.  In Table  H,  the  results  of two  experiments 
using (CBA  X  C57BL)F1 mice as both donors and recipients, are shown. A 
mixed inoculum of one million thoracic duct cells and 10 million bone marrow 
cells did not increase the number of hemolytic loci per spleen over that pro- 
duced by one million thoracic duct cells alone but greatly increased the num- 
ber of PFC per spleen. 
A time course study of the production of hemolytic loci and PFC per spleen 
was performed in heavily irradiated CBA mice injected with SRBC and one 
million CBA thoracic duct cells, 10 million CBA bone marrow ceils or a  mixed 
inoculum of both cell types. 4-9 days after irradiation and cell inoculation, 
half the number of spleens were assayed for their content of PFC  and the 
other half were serially sectioned to determine the number of hemolytic foci. 
The results are shown in Figs.  I  and 2.  The majority of heavily irradiated 
CBA mice of our colony had died by 9 days unless they were given hemopoietic 824  CELL  TO  CELL  INTERACTION  IN  U~,~UNE  RESPONSE.  II 
cells. Hence adequate data was not available at 9 days in the case of irradiated 
mice injected with SRBC and thoracic duct cells alone. At day 8, one million 
thoracic duct cells produced on the average about 100 PFC and five hemolytic 
loci per spleen. Addition of bone marrow cells to the inoculum of thoracic duct 
cells significantly increased the number of PFC per spleen to about 900 (P  < 
0.01) but did not increase the number of hemolytic foci. As the loci presumably 
represent discrete dusters of PFC,  it can  be calculated  that,  at the peak of 
the response, the foci resulting from inoculation of thoracic duct cells contain 
about 20 PFC. The addition of bone marrow cells  increased this number  to 
TABLE II 
ltemolylic  Foci and PFC Produced in the Spleens of Heavily Irradiated  (CBA  X  C57BL)F1 
Mice after Injection of SRBC and Syngeneic F1 Thoracic Duet and FI Bone 
Marrow Cells 
Cells inoculated 
SRBC only 
I0 X  I0  6 bone marrow cells  + 
SRBC 
I0  e  thoracic  duct cells  +  SRBC 
10  6 thoradc duct cells +  10 X 
10  6  bone  marrow  cells  + 
SRBC 
Hemolytic  loci 8 days postirradiation 
tNe~df I  No, o, foeJ per spleen 
i*'°  oO:  o: 0:0 0 o 0,  ,, 
!  12  3,  3,  3, 4,  5,  5,  5,  6,  6,  7, 
8, 8 
13  2, 2, 3, 3, 3, 6, 6, 6, 7, 7, 7, 
7, 10 
PFC 8 days post- 
irradiation 
No. of  Average No. of 
mice  PFCper spleen 
tested  (-4- sg) 
8  12  -4-3.5 
4  31  4- 2.9 
13  44 4-  12.3 
16  527  4-  75.4 
approximately 160 PFC. The 7-9 day PFC response of irradiated CBA mice in- 
jected with  10 million CBA bone  marrow cells varied from 27  4-  5.8 in one 
series of experiments (Table I) to  110 4- 21.1 in another (Fig. 1). The number 
of hemolytic loci in bone marrow-injected  mice however never increased  sig- 
nificantly above  the  background number of one hemolytic focus per  spleen 
obtained in irradiated mice injected with either SRBC only or lymphoid cells 
only. These results indicate that while irradiated mice given SRBC  and tho- 
racic duct cells alone can produce PFC,  this response is greatly increased by 
the simultaneous injection of bone marrow cells. 
When thymus cells were used  instead of thoracic duct cells,  it was evident 
that even 50 million thymus cells failed to achieve the same effect as one million 
thoracic duct cells in irradiated mice  injected with SRBC and bone marrow 
(Table III). Therefore thoracic duct cells were far superior to thymus cells in 
this system in  contrast  to what  was  observed in neonataUy thymectomized 
mice (1). This finding prompted the following studies in adult thymectomized 
irradiated mice injected with bone marrow. G. F. MITCHELL  AND  ]. ~. A; P. MILLER  825 
Effect  of Syngeneic  Thymus or Thoracic Duct Cells in Thymectomiud Irradi- 
ated Bone Marrow-Protected  Hosts.--lO million CBA thymus or thoracic duct 
cells  were  injected  together  with  SRBC  into  adult  thymectomized mice  2 
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FIG. 1. PFC produced in the spleens  of heavily irradiated CBA mice injected, after irradia- 
tion, with SRBC alone (A), SRBC and 1 million syngeneic  thoracic duct cells ($  @), 
SRBC and 10 million syngeneic  bone marrow cells (b .... A), and SRBC and a mixed inocu- 
lure of 1 million syngeneic thoracic duct cells and 10 million syngeneic  bone marrow cells 
(0~0).  The magnitude of twice the standard errors is shown by the vertical bars. Each 
point at 4, 5, and 9 days represents the mean of determinations made on 2-5 mice and at 
6, 7, and 8 days on 6-13 mice. 
wk after irradiation and marrow  protection. The number of PFC per spleen 
was determined 2, 4, 5, 7, and 10 days thereafter. From Fig. 3 it can be seen 
that while mice given thoracic duct cells produced 72,000 PFC, mice receiving 
the same number of thymus  cells could produce only about 6000 PFC at the 826  CELL  TO  CELL  INTERACTION  IN  ~UNE  RESPONSE.  II 
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FIo. 2. Hemolytic loci produced in the spleens of heavily irradiated  CBA mice injected 
after irradiation with SRBC alone  (A),  1 million syngeneic thoracic duct  cells alone  (r-l), 
SRBC and 1 million syngeneic thoracic duct cells (O  O), SRBC and 10 million syngeneic 
bone marrow cells (A .... A), and SRBC and a mixed inoculum of 1 million syngeneic tho- 
racic  duct cells and 10 million syngeneic bone marrow  cells  (Ore-O).  The magnitude of 
twice the standard errors is shown by the vertical bars. Each point at 4, 5, and 9 days repre- 
sents the mean of determinations made on 2-4 mice and at 6,  7, and 8 days on 6-14 mice. G.  ~'.  MITCHELL  AND  J.  F.  A.  P.  MILLER  827 
height  of  the  response.  Mice  injected with  SRBC  only gave less  than  300 
PFC. In the case of thoracic duct ceil recipients, the number of PFC increased 
12-fold between days 4 and 5. When the data for 10 million thoracic duct cells 
are compared in Table I  and Fig. 3,  it is evident that far more PFC were pro- 
duced in the bone marrow-protected  thymectomized irradiated hosts than in 
the irradiated hosts not given bone marrow. 
It is apparent,  therefore,  that thymus cells are not as effective as thoracic 
duct ceils in thymectomized irradiated bone marrow-protected hosts in con- 
trast  to  the  situation  (1)  in  neonatally  thymectomized mice.  One  notable 
difference between the  two hosts  was  the size of their  spleens.  Thus,  seven 
mice which had been thymectomized  at 6  wk,  irradiated  and  injected with 
TABLE III 
PFC Produced in the Spleens of Heavily Irradiated CBA  Mi~e after Injection of SRBC and 
Syngeneic Thymus or Tkoracic Du~t Cells togetker ~itk Bone Marrow Cells 
Cells inoculated 
SRBC 
10 X 10  e bone marrow ceils q- SRBC 
50 X 10  s thymus cells -1- SRBC 
50 X 10  e thymus cells -k 10 X 10  e bone marrow cells q- SRBC 
106 thoracic duct cells q- SRBC 
106 thoracic duet cells q- 10 X 106 bone marrow ceils +  SRBC 
~o  o  c  [  Average PFC per  :.o"  [spleen 8 days post- 
~'---~ I"  irradi._._  stio...n (-4- S__._...~) 
12  ]  13  4-  1.8 
15  [  73  4-  23.5 
20  I  52  -4-  19.3 
13  522  4- 341 
10  97  4- 34.7 
13  [  877 4- 218 
bone marrow cells had an average of 8l -4- 7.0 million nucleated spleen cells 2 
wk after irradiation, which  is  significantly less  than  the  average number of 
148 million  cells in  the  spleens of neonatally thymectomized mice  (1). The 
possibility that this accounts for the different results will be discussed later. 
Effect of Allogeneic Thymus, Thoracic Duct, and Bone Marrow Cells in Irradi- 
ated Hosts.--In  order to identify, by means of anti-H2 sera,  the identity of 
PFC produced in irradiated hosts in response to SRBC and thymus, thoracic 
duct and bone marrow cells,  ailogeneic combinations must be used.  Accord- 
ingly,  (CBA  X  C57BL)Fx  thoracic  duct  cells  were  injected  together  with 
SRBC and CBA bone marrow into heavily irradiated CBA mice. The results 
of  two  representative experiments  are  shown  in  Table  IV.  When  a  mixed 
inoculum of Fx thoracic duct cells,  CBA bone marrow cells,  and SRBC was 
given on the day of irradiation, 800 PFC appeared in the spleens 7 days later. 
This was only slightly greater than the sum of the mean number of PFC pro- 
duced in  the  spleens of mice given either SRBC  alone,  SRBC  and  thoracic 828  CELL TO CELL INTERACTION  IN rM'M-UIg"E  RESPONSE. II 
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FIG. 3. PFC produced in the spleens of adult thymectomized CBA mice, heavily irradiated 
and protected with syngeneic bone marrow cells 2 wk previously, and injected with SRBC 
alone (A  A), SRBC and 10 million syngeneic thymus cells (O  O), and SRBC and 
10 million syngeneic thoracic duct cells (O~O).  The magnitude of twice the standard 
errors is shown by the vertical bars. Each point represents the mean of determinations made 
on 3-10 mice. 
duct cells, or SRBC and bone marrow cells.  6 These results therefore contrast 
with  those  obtained when  syngeneic combinations of  cells  were  used  (v/de 
suFfa).  Attempts were  then made  to determine whether synergism between 
6 Likewise, when irradiated  F1 mice were used, instead  of CBA mice, as recipients of a 
mixed inoculum of  SRBC, Fx thoracic duct cells and CBA hone marrow, no convincing 
synergistic effect was obtained. G. P. MITCHELL  AND  ~. ]?. A. P. MILLER  829 
allogeneic cells could take place in irradiated hosts if CBA bone marrow cells 
were allowed to reside in their hosts for a  period of time before introducing 
F1 thoracic duct cells and antigen. As shown in Table IV, giving thoracic duct 
cells and SRBC 2 days after bone marrow did not obviously augment the PFC 
response.  Increasing  this  interval  still  further  was  not  attempted  in  these 
irradiated hosts since it is well known that immunological recovery takes place 
in irradiated mice given bone marrow. If adult mice are thymectomized prior 
to irradiation and bone marrow protection, however, the recovery of immuno- 
logical capacity is impaired (8). This type of host was therefore chosen to deter- 
TABLE  IV 
PFC Produced in the Spleens of Heartily Irradiated CBA Mice after Injection of SRBC, 
(CBA  X  C57BL)F1 Thoracic Duct, amt CBA Bone Marrow Cells 
Exp,  Cells inoculated 
6X 106 Ft thoracic duct cells +  10 X  106 CBA bone mar- 
row celh +  SRBC 
6 X  10  6 F1 thoracic duct cells +  SRBC 
I0 X  10  6 CBA bone marrow cells +  SRBC 
SRBC only 
10 X  106 CBA bone marrow cells followed 2 days later by 
3 X  106 Ft thoracic duct cells +  SRBC 
10 X  106 CBA bone marrow cells followed 2 days later by 
SRBC 
3 X 10  6 F1 thoracic duct cells +  SRBC 
SRBC only 
Average 
PFC per 
spleen 7 
days after 
SRBC 
800 
593 
116 
19 
496 
103 
228 
43 
mine whether synergism between allogeneic cells can take place. 10 million Ft 
thymus or thoracic duct cells were injected  2  wk after protecting irradiated 
adult  thymectomized CBA  mice with  CBA  bone  marrow.  The  results  of a 
time course study on the PFC responses of these mice are shown in Fig. 4. 
Thoracic duct cells increased the response to 19,800 PFC at the peak. Thymus 
cells failed  to produce  an increase. A  comparison of the  results  obtained  in 
Figs. 3  and 4  dearly shows that, in thymectomized irradiated bone marrow- 
protected hosts, syngeneic cells are more effective than semiallogeneic cells. 
Identity of the Hemolysin Plaque-Forming Cells.--When  spleen cell suspen- 
sions containing PFC were incubated with specific isoantisera the number of 
detectable PFC was reduced by 80--100 %. Nonspeeitic isoantisera or normal 
mouse sera reduced the number to an insignificant extent (1). 
Spleen cells from irradiated CBA mice given Fx thoracic duct cells and SRBC 
on the day of irradiation were incubated with normal CBA or C57BL serum, 830 
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Fzo. 4. PFC produced in the spleens of adult thymectomized CBA mice, heavily irradiated 
and protected with syngeneic bone marrow  cells 2 wk previously, and injected with SRBC 
alone  (&  &),  SRBC  and  10 million  semiailogeneic  (CBA  X  C57BL)Ft  thymus ceils 
(O"  O),  and  SRBC  and  10  million  semi~llogeneic Ft  thoracic duct  cells  (e  e). 
The magnitude of twice the standard errors is shown by the vertical bars. Each point rep- 
resents the mean of determinations made on 2-10 mice. 
anti-CBA serum or anti-C57BL serum.  The results of three experiments with 
14  mice injected with  various  numbers  of  thoracic  duct  cells  are  shown  in 
Table V. Anti-CBA serum reduced the number  of PFC  by 85-93 %  and anti- 
C57BL  serum reduced the number  by 85-95 %.  It is thus  apparent  that  the 
PFC produced in these hosts were derived from the inoculated cells. G.  1~'. MITCHELL  AND  3.  1L  A.  P.  MILLER  831 
The number of PFC produced following an inoculation of F1 thoracic duct 
cells and SRBC was far greater in adult thymectomized irradiated CBA mice 
injected with CBA bone marrow than in irradiated  mice not receiving bone 
marrow (cf. Tables V and VI). In Table VI are shown the results of incubating 
TABLE V 
PFC from Spleens of Reconstituted Irradiated CBA Mi~e Remaining after Incubation 
with Isoantisera 
Cells used  for reconstltution 
X  I0  e FI thoracic  duct cells 
[0 X  106 Fa thoracic  duct cells 
~0 X  l0  s  FI thoracic  duct cells 
No. of 
spleens 
in pool 
Average 
PFC per 
spleen at 
7 days 
593 
822 
5,655 
No. of PFC per aliquot remaining after 
mcubation with: 
Normal 
mouse  Anti-CBA serum  Anti-C57BL 
8eraixt 
seruln 
98  14  (85%)* 
72  6 (92%) 
432  32  (93%) 
11  (89%) 
11  (85%) 
21  (95%) 
* Number in brackets refers to per cent reduction. 
TABLE VI 
PFC from Spleens of Reconstituted Thymectomized Irradiated CBA Mice Remaining 
after Incubation with lsoantlsera 
Cells used  or reconstitution* 
10 X l0  s F1 thoracic  duct cells 
10 X l0  s F1 thoracic  duct cells 
35 X  10  e  FI thoracic  duct cells 
35 X  I06 FI thoracic  duct cells 
No. of 
spleens 
in pool 
Average 
PFC per 
spleen 
5  10,980 
5  18,262§ 
2  69,300 
2  85,850 
No. of PFC per aliquot remaining after 
incubation with: 
Normal 
mouse 
$eruin 
80 
139 
604 
1454 
Anti-CBA  Anti-CS?BL 
serum  serttnl 
4  (95%)~  88  (0%) 
6 (96%)  140  (O%) 
20  (97%)  571  (5%) 
70  (95%)  1660 (0%) 
* F1 thoracic duct cells were inoculated  wk postirradiation and marrow protection. 
Number in brackets refers to per cent reduction. 
§ Spleens assayed 7 days after thoracic duct cells were inoculated; all others were assayed 
5 days after inoculation. 
with isoantisera, aliquots of spleen cells from thymectomized irradiated recipi- 
ents of Fx thoracic duct cells and CBA bone marrow. Anti-CBA serum caused 
a reduction in the number of PFC of 95-97 % and anti-C57BL resulted in losses 
of up to 5 %. The majority of PFC produced in these hosts was therefore de- 
rived not from inoculated Fx thoracic duct cells but from CBA cells. 
DISCUSSION 
Cells capable of producing hemolytic foci in the spleens of heavily irradiated 
mice, above the background number, were detected in  thoracic duct lympho- 832  CELL  TO  CELL  INTERACTION  IN  IMMUNE  RESPONSE.  II 
cyte suspensions  but not in bone marrow. In irradiated recipients of thoracic 
duct cells and SRBC, the addition of syngeneic bone marrow did not increase 
the number of hemolytic foci but increased the number of PFC per spleen to 
a far greater extent than could be accounted for by  summating the activities 
of either cell population alone. These results can be interpreted in at least two 
ways. (a) By allowing hemopoietic regeneration and possibly creating a favor- 
able environment in the spleen, bone marrow promotes the differentiation and 
multiplication  of PFC precursors present in thoracic duct lymph. Such PFC 
precursors were described as antigen-sensitive ceils by Kennedy et al.  (5) who 
considered that the PFC clustered within an area detectable by the hemolytic 
focus assay technique, were the direct descendants of an antigen-sensitive cell 
that had lodged in the spleen  at the site where the focus arose.  As bone mar- 
row did not produce foci,  these investigators  concluded that  it  lacked  anti- 
gen sensitive  cells  or PFC precursors  according  to  their  definition.  (b)  The 
second  possibility is  that  bone  marrow  does  provide  PFC  precursors  (the 
AFCP in our terminology) the differentiation of which can be induced only by 
the  associated presence of some type of cell,  presumably derived originally 
from the  thymus and present in  thoracic duct lymph  (the ARC in our ter- 
minology). Clearly, in order to distinguish between these two possibilities,  one 
must identify the source of PFC in irradiated mice receiving bone marrow and 
thoracic duct or thymus lymphocytes. 
In the experiments of Davies et al.  (9-11),  thymectomized irradiated mice 
were protected with bone marrow and thymus from donors which were slightly 
different  immunogenetically.  When  the  spleens  from  these  thymus-grafted 
mice were transferred soon after challenge  with SRBC, into irradiated recipi- 
ents  presensitized  against  either  the  thymus-donor  or  the  marrow-donor, 
those capable of rejecting cells of thymus donor-type were able to produce 
antibody in response to SRBC. By contrast,  those immunized against marrow 
donor-type  cells  produced  much  less  antibody.  These  transfer  experiments 
were, however, performed 30 days after irradiation and thymus grafting. It is 
known that,  at that time, the lymphoid cell population of the graft has been 
replaced entirely by cells derived from the bone marrow (12). Thus hemolysins 
detected in  irradiated  mice,  presensitized  against  thymus donor-type  cells, 
may have been produced by bone marrow-derived cells which had repopulated, 
and migrated from, the thymus graft. Hence the cells producing antibody could 
have the immunogenetic characteristic of the marrow donor and yet be thy- 
mus derived. Thus, "it may be that thymus-derived cells can produce antibody, 
but only in the presence of cells of bone marrow origin.  Equally, cells of bone 
marrow origin.., may be the cells whose immunological  potential is enhanced 
by association with cells of thymic origin.  These are not problems which the 
present analysis can resolve" (11). 
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the identity of the PFC produced in the spleens  of irradiated recipients of a 
mix~A inoculum of F1 thoracic duct lymphocytes, CBA bone marrow cells, and 
SRBC, because no synergistic effect was observed in this experimental system. 
This contrasts with the results obtained in the syngeneic situation but is in 
general  agreement with  a  previous report indicating  that  allogeneic  thymus 
and bone marrow cells do not interact in irradiated hosts (13). Since it appears 
that a  synergistic effect can be obtained only in syngeneic systems, methods 
other than those using anti-H2 sera must be devised to determine the source 
of the PFC. The only technique available so far is the detection of a particu- 
lar  chromosome marker  in  individual  antibody-formlng  cells  (14).  This  has 
been applied  to PFC  obtained from  the  spleens of heavily irradiated mice 
injected simultaneously after irradiation with CBA/T6T6 bone marrow cells, 
CBA thoracic duct cells, and SRBC and the results will be given in the follow- 
ing paper (15).  ~ 
The reason for the failure of an interaction to take place between allogeneic 
lymphocytes and bone marrow cells immediately following  transfer to irradi- 
ated hosts, is unknown but it may be that the  phenomenon of allogeneic inhi- 
bition (16) operates. If this is so, however, it no longer operates once differen- 
tiation  of some bone marrow  stem  cell  has  taken  place,  since  an  excellent 
synergistic effect was obtained in thymectom~zed  irradiated mice receiving F1 
thoracic duct cells and SRBC 2 wk after an injection of CBA bone marrow. 
In this system, therefore, techniques using anti-H2 sera were used to determine 
the identity of the PFC produced. The results indicate that the bone marrow 
must be a  source of AFCP since  the PFC were CBA-type and not F1-type. 
This conclusion  is corroborated by the results obtained in the following study 
in which chromosome marker  techniques were used  (15).  It seems therefore 
that bone marrow provides AFCP, but not cells capable of initi~ing the pro- 
duction of hemolytic loci, so that it must lack ARC. The hemolytic focus assay 
is thus a measure, not of the number of PFC precursors in a given population, 
but of the number of ARC which settle in the irradiated spleens. 
Irradiated recipients of thymus cells and SRBC will produce neither hemo- 
lytic loci nor PFC in their spleens (5,  17-19),  When bone marrow is added, 
however, both hemolytic loci and an increase in the number of PFC per spleens 
can be detected (17-19). One of the differences between the population of cells 
from  thymus and  thoracic duct lymph, which  could not have been demon- 
strated in the experimental system used in the previous study (1), is that PFC 
can be derived directly from some thoracic duct lymphocytes, but not from 
thymus cells. The evidence for this is that PFC were produced in the spleens 
of heavily irradiated  recipients  of syngeneic thoracic  duct  cells  but not  of 
thymus cells, and that the PFC in the spleens of irradiated CBA mice injected 
with F1 thoracic duct cells were F1 type. All the evidence obtained in this and 
the previous study therefore suggests that the thymus contains only ARC, the 834  CELL  TO  CELL  INTERACTION  IN  IMMUNE  RESPONSE.  II 
bone marrow only AFCP, but the thoracic duct lymph contains both ARC 
and  AFCP.  Preliminary  studies  using  density gradient  centrifugation  tech- 
niques indicate that the two cell types in thoracic duct lymph may indeed be 
separated. 
It is evident from a lot of experimental data that the immunological  activity 
of thymus cells is inferior  to that of spleen or lymph node cells (20).  For in- 
stance, mouse thymus cells injected with rat erythrocytes into preirradiated 
mice enable their hosts to produce much less antibody than a  similar number 
of spleen cells (21).  Furthermore, in order to prevent the protective action of 
allogeneic bone marrow in irradiated mice two to four times as many syngeneic 
thymus lymphocytes as syngeneic lymph node cells were required (22, 23). In 
the present experiments,  a  comparison was made between the peak PFC re- 
sponse of irradiated recipients of thymus and bone marrow on the one hand, 
and of thoracic duct cells and bone marrow on the other.  Far more thymus 
than  thoracic  duct lymphocytes were required  to  cooperate with  a  certain 
number of bone marrow cells in order to produce a given number of PFC. The 
mean PFC response in irradiated recipients of thymus and bone marrow was 
greater than that of mice given either cell population alone,  but there was a 
considerable variation  between individual  mice  (Table III).  The  synergistic 
effect in these experiments was much less impressive than  that  reported by 
Claman et al. (17), perhaps because they gave two injections of SRBC to their 
irradiated  recipients whereas only one such injection  was given here at the 
time of cell transfer. Thymus cells were also less effective than thoracic duct 
ceils in thymectomized irradiated,  bone marrow-protected mice.  This differ- 
ence between the two cell types was not evident in neonatally thymectomized 
recipients (1). The spleens of these mice were much larger than those of thy- 
mectomized irradiated  mice.  It is possible that the larger  spleens trap more 
thymus cells since these cells preferentially home there rather than to lymph 
nodes  (24,  25).  Thoracic duct cells, however, have a  capacity to recirculate 
and to home to all the lymphoid tissues (26). These features might account for 
the different results obtained in neonatally thymectomized and in adult thy- 
mectomized  irradiated,  bone marrow-protected  mice.  An alternative  possi- 
bility is that  a  particular  cell  type, which is radiosensitive and required for 
antigen handling in this system, is present in spleen and thoracic duct lymph, 
but absent from the thymus lymphocyte population.  Neonatal thymectomy 
would presumably not affect this cell type. 
As a general conclusion,  it may be said that there are ARC in the  thymus 
but in a proportion that is much less than that found in the cell population of 
thoracic duct lymph,  spleen,  and  lymph nodes.  Perhaps ARC  are exported 
out of the thymus as soon as they are formed so that the thymus would contain 
a  greater  proportion  of "immature"  cells.  Perhaps  emigrating  thymus  cells 
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this  maturation entails  interaction with  antigen  (or  macrophageoprocessed 
antigen) to give rise to a clone of cells that are specifically reactive to the par- 
ticular antigen (? memory cells). Perhaps only these cells are capable of re- 
circulating so that the population of cells in thoracic duct lymph would be 
richer in ARC than that in the thymus. Whatever the case may be, it seems 
evident that in the 195  immune response  to SRBC, some interaction takes 
place  between  thymus-derived ARC  and  bone  marrow-derived AFCP  and 
that this allows the differentiation of the AFCP to PFC. Whether a similar 
interaction takes place in other antigenic systems is not known but it would 
seem more likely to occur only in those immune responses which are initiated 
by cells the development of which is under thymus control. 
SUMMARY 
The number of discrete hemolytic foci and of hemolysin-formlng  cells arising 
in the spleens of heavily irradiated mice given sheep erythrocytes and either 
syngeneic  thymus or  bone  marrow  was not significantly greater than that 
detected in  controls given  antigen alone.  Thoracic duct cells injected with 
sheep  erythrocytes signiiicaatiy increased  the number of hemolytic loci and 
10 million  cells gave rise to over  1000 hemolysin-forming  cells per spleen. A 
synergistic effect was observed when syngeneic thoracic duct cells were mixed 
with syngeneic marrow cells: the number of hemolysin-forming cells produced 
in this case was far greater than could be accounted for by summating the 
activities of either cell population given alone. The number of hemolytic foci 
produced by the mixed  population was not however  greater than that pro- 
duced by an equivalent number of thoracic duct cells given without bone 
marrow. Thymus cells given together with syngeneic  bone marrow enabled 
irradiated mice to produce hemolysin-formlng  cells but were much less effec- 
tive than the same number of thoracic duct cells. Likewise syngeneic thymus 
cells were not as effective  as thoracic duct cells in enabling  thymectomized 
irradiated bone marrow-protected hosts  to produce  hemolysin-forming  cells 
in response to sheep erythrocytes. 
Irradiated recipients  of semiallogeneic thoracic duct cells produced hemoly- 
sin-forming cells of donor-type as shown by the use of anti-H2 sera. The iden- 
tity of the hemolysin-forming cells in the spleens of irradiated mice receiving 
a mixed inoculum of semiallogeneic thoracic duct cells and syngeneic marrow 
was not determined because no synergistic effect was obtained in these recipi- 
ents in  contrast  to  the  results  in  the  syngeneic  situation.  Thymectomized 
irradiated mice protected with bone marrow for a period of 2 wk and injected 
with semiallogeneic thoracic duct cells together with sheep erythrocytes did 
however produce  a far greater number of hemolysin-forming cells than irradi- 
ated  mice  receiving  the  same number  of  thoracic duct cells without bone 
marrow. Anti-H2 sera revealed  that  the antibody4orming cells arising in the 836  CELL  TO  CELL  INTERACTION  IN  IMMUNE  RESPONSE.  II 
spleens of  these  thymectomized  irradiated  hosts were derived,  not  from the 
injected thoracic duct  ceils, but from bone marrow. 
It is concluded  that thoracic  duct lymph contains a  mixture of cell types: 
some  axe hemolysin-forming  cell  precursors  and  others  are  antigen-reactive 
cells which can interact with antigen and initiate the differentiation of hemoly- 
sin-formlng cell precursors  to  antibody-formlng cells.  Bone  marrow contains 
only precursors of hemolysin-formlng cells  and thymus contains only antigen- 
reactive cells but in a proportion that is  far less than in thoracic duct lymph. 
We wish to thank  Miss Winifred House, Miss Susie Bath,  Miss Sue Hughes, and  Miss 
Catriona Jelbart for technical assistance. 
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